Skip to main content

Journal of Neuro-Oncology

Ausgabe 3/2016

Inhalt (26 Artikel)

Topic Review

How to train glioma cells to die: molecular challenges in cell death

Jeffrey Wojton, Walter Hans Meisen, Balveen Kaur

Laboratory Investigation

Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma

Tina Dasgupta, Aleksandra K. Olow, Xiaodong Yang, Rintaro Hashizume, Theodore P. Nicolaides, Maxwell Tom, Yasuyuki Aoki, Mitchel S. Berger, William A. Weiss, Lukas J. A. Stalpers, Michael Prados, C. David James, Sabine Mueller, Daphne A. Haas-Kogan

Erratum

Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma

Tina Dasgupta, Aleksandra K. Olow, Xiaodong Yang, Rintaro Hashizume, Theodore P. Nicolaides, Maxwell Tom, Yasuyuki Aoki, Mitchel S. Berger, William A. Weiss, Lukas J. A. Stalpers, Michael Prados, C. David James, Sabine Mueller, Daphne A. Haas-Kogan

Laboratory Investigation

Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway

Harshil D. Dhruv, Alison Roos, Patrick J. Tomboc, Serdar Tuncali, Ashley Chavez, Ian Mathews, Michael E. Berens, Joseph C. Loftus, Nhan L. Tran

Laboratory Investigation

Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice

Noah C. Jenkins, Ganesh Rao, Charles G. Eberhart, Carolyn A. Pedone, Adrian M. Dubuc, Daniel W. Fults

Laboratory Investigation

Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells

Richard E. Kast, Susana Ramiro, Sandra Lladó, Salvador Toro, Rafael Coveñas, Miguel Muñoz

Laboratory Investigation

The effect of regadenoson-induced transient disruption of the blood–brain barrier on temozolomide delivery to normal rat brain

Sadhana Jackson, Nicole M. Anders, Antonella Mangraviti, Teresia M. Wanjiku, Eric W. Sankey, Ann Liu, Henry Brem, Betty Tyler, Michelle A. Rudek, Stuart A. Grossman

Laboratory Investigation

TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas

Umberto Nencha, Amithys Rahimian, Marine Giry, Andrea Sechi, Karima Mokhtari, Marc Polivka, Yohann Schmitt, Anna-Luisa Di Stefano, Agusti Alentorn, Marianne Labussière, Marc Sanson

Laboratory Investigation

Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity

Leslie L. Muldoon, Michael A. Pagel, Joao Prola Netto, Edward A. Neuwelt

Laboratory Investigation

XBP1 silencing decreases glioma cell viability and glycolysis possibly by inhibiting HK2 expression

Yaohua Liu, Xu Hou, Min Liu, Zhuowen Yang, Yunke Bi, Huichao Zou, Jianing Wu, Hui Che, Chenguang Li, Xiaoxiong Wang, Kaikai Wang, Chen Zhong, Jiakang Zhang, Tao Yu, Qilong Bian, Shuang Chai, Huailei Liu, Jing Ai, Shiguang Zhao

Clinical Study

Prognostic value of combined visualization of MR diffusion and perfusion maps in glioblastoma

Katerina Deike, Benedikt Wiestler, Markus Graf, Caroline Reimer, Ralf O. Floca, Philipp Bäumer, Philipp Kickingereder, Sabine Heiland, Heinz-Peter Schlemmer, Wolfgang Wick, Martin Bendszus, Alexander Radbruch

Clinical Study

Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas

David Taïeb, Anne Barlier, Chunzhang Yang, Morgane Pertuit, Aurélie Tchoghandjian, Claire Rochette, Hélène Zattara-Canoni, Dominique Figarella-Branger, Zhengping Zhuang, Karel Pacak, Philippe Metellus

Clinical Study

Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery

Samuel M. Shin, Benjamin T. Cooper, Abraham Chachoua, James Butler, Bernadine Donahue, Joshua S. Silverman, Douglas Kondziolka

Clinical Study

Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients

Joanna Socha, Lucyna Kepka, Sunita Ghosh, Wilson Roa, Narendra Kumar, Valery Sinaika, Juliana Matiello, Darejan Lomidze, Douglas Guedes de Castro, Dalenda Hentati, Elena Fidarova

Clinical Study

Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases

Chao Tang, Zhen-yu Zhang, Ling-chao Chen, Zelin Sun, Yi Zhang, Zhiyong Qin, Yu Yao, Liang-fu Zhou

Clinical Study

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Marco Losa, Fausto Bogazzi, Salvo Cannavo, Filippo Ceccato, Lorenzo Curtò, Laura De Marinis, Donato Iacovazzo, Giuseppe Lombardi, Giovanna Mantovani, Elena Mazza, Giuseppe Minniti, Maurizio Nizzoli, Michele Reni, Carla Scaroni

Clinical Study

Outcome of patients with malignant glioma and synchronous or metachronous non-central nervous system primary neoplasms

Mohamed A. Hamza, Carlos Kamiya-Matsuoka, Diane Liu, Ying Yuan, Vinay K. Puduvalli

Clinical Study

Presurgical navigated TMS motor cortex mapping improves outcome in glioblastoma surgery: a controlled observational study

Thomas Picht, Dietmar Frey, Stefan Thieme, Stefan Kliesch, Peter Vajkoczy

Clinical Study

Stereotactic radiosurgery (SRS) in high-grade glioma: judicious selection of small target volumes improves results

Felix Bokstein, Deborah T. Blumenthal, Benjamin W. Corn, Eliahu Gez, Diana Matceyevsky, Natan Shtraus, Zvi Ram, Andrew A. Kanner

Clinical Study

Pseudoprogression in glioblastoma patients: the impact of extent of resection

Hun Ho Park, Tae Hoon Roh, Seok Gu Kang, Eui Hyun Kim, Chang-Ki Hong, Se Hoon Kim, Sung Soo Ahn, Seung Koo Lee, Hye Jin Choi, Jaeho Cho, Sun Ho Kim, Kyu-Sung Lee, Chang-Ok Suh, Jong Hee Chang

Clinical Study

Usefulness of 11C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions

Atsushi Watanabe, Yoshihiro Muragaki, Takashi Maruyama, Jun Shinoda, Yoshikazu Okada

Clinical Study

Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme

Christian Henker, Thomas Kriesen, Katharina Fürst, Deborah Goody, Änne Glass, Brigitte M. Pützer, Jürgen Piek

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.